D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ATXS holding history
Astria Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXS overviewAll 13F holders of ATXSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −82,925−100.0% | Sold out | Holders |
| Q3 2025 | 82,925 | $603.7K | <0.1% | +529+0.6% | Added | Holders |
| Q2 2025 | 82,396 | $441.6K | <0.1% | +63,639+339.3% | Added | Holders |
| Q1 2025 | 18,757 | $100.2K | <0.1% | +7,382+64.9% | Added | Holders |
| Q4 2024 | 11,375 | $101.7K | <0.1% | +1,207+11.9% | Added | Holders |
| Q3 2024 | 10,168 | $112.0K | <0.1% | −14−0.1% | Reduced | Holders |
| Q2 2024 | 10,182 | $92.7K | <0.1% | +10,182 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −24,809−100.0% | Sold out | Holders |
| Q1 2022 | 24,809 | $166.0K | <0.1% | −13,398−35.1% | Reduced | Holders |
| Q4 2021 | 38,207 | $206.0K | <0.1% | −7,863−17.1% | Reduced | Holders |
| Q3 2021 | 46,070 | $407.0K | <0.1% | +46,070 | New | Holders |